By Laura Cooper
Tobacco giant Altria Group has stopped selling its NJOY Ace e-cigarettes, after the U.S. International Trade Commission sided with rival Juul Labs in a patent dispute. Consumers can still buy them in stores until retailers' existing inventory runs out.
The ruling was a setback for Altria, which in 2023 divested its investment in Juul and agreed to buy NJOY for at least $2.75 billion. Juul then filed a complaint with the ITC, alleging that the NJOY Ace infringed on its patents. The ITC in January ordered Altria to stop importing, distributing and marketing the devices by March 31. Shares of Altria were down about 2% in midday trading Tuesday.
Among the NJOY products removed from the market is the only menthol vaping product authorized for sale in the U.S. by the Food and Drug Administration. Altria Chief Executive Billy Gifford, on a January conference call with analysts, said the ITC's decision limits consumers' choices and "undermines public health, especially in context of a market that is overrun by illicit products."
Write to Laura Cooper at laura.cooper@wsj.com
(END) Dow Jones Newswires
April 01, 2025 15:55 ET (19:55 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.